Bone Mass Effects of Cross-Sex Hormone Therapy in Transgender People: Updated Systematic Review and Meta-Analysis.

Tayane Muniz FigheraPatrícia Klarmann ZiegelmannThaís Rasia da SilvaPoli Mara Spritzer

Published in: Journal of the Endocrine Society (2019)

Long-term CSHT had a neutral effect on BMD in transgender men. In transgender women, only lumbar spine BMD seemed to be affected after CSHT. This evidence is of low to moderate quality as a result of the observational design of studies, small sample sizes, and variations in hormone therapy protocols.

Keyphrases

hiv testing
bone mineral density
high intensity
type diabetes
stem cells
cross sectional
middle aged
adipose tissue
quality improvement
skeletal muscle
pregnancy outcomes
hepatitis c virus
cell therapy
bone loss
breast cancer risk